Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2010; 16(45): 5651-5661
Published online Dec 7, 2010. doi: 10.3748/wjg.v16.i45.5651
Published online Dec 7, 2010. doi: 10.3748/wjg.v16.i45.5651
Drug | Pattern of liver damage | Proposed mechanism | Incidence |
Aspirin | Acute and chronic hepatitis | Dose dependent | Low |
Reye’s syndrome | > with high dose | ||
Diclofenac | Acute and chronic hepatitis | Metabolic | Low |
Mixed damage and pure cholestasis | Immunologic | ||
Sulindac | Acute hepatitis and mixed injury | Hypersensivity | Moderate |
Ibuprofen | Acute hepatitis, ductopenia | Metabolic | Low |
Naproxen | Cholestatic, mixed damage | Metabolic | Low |
Coxibs | Acute hepatitis, mixed damage | Probably metabolic | Low |
Oxicams | Acute hepatitis, massive and submassive necrosis, cholestasis and ductopenia | Metabolic | Low |
Nimesulide | Acute hepatitis, pure cholestasis | Probably metabolic | Moderate |
- Citation: Bessone F. Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? World J Gastroenterol 2010; 16(45): 5651-5661
- URL: https://www.wjgnet.com/1007-9327/full/v16/i45/5651.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i45.5651